Sets evidence strategy for physician- and regulator-facing use by defining and executing a multiāyear roadmap for how evidence is identified, assessed, synthesized, and translated across the NM+PH portfolio to strengthen evidence used in clinical and regulatory decision-making.
Our Neuromodulation Operating Unit provides advanced, personalized therapies for chronic pain, movement disorders, and other neurological conditions, using technologies such as spinal cord stimulation, deep brain stimulation, and targeted drug delivery systems to restore function, reduce symptoms, and improve quality of life worldwide.